defenseworld.net · Nov 11, 2026
NASDAQ · MRNA
Moderna, Inc. (MRNA) Stock Price, Chart, News & Analysis
View the latest Moderna, Inc. (MRNA) stock price, interactive chart, financial metrics, company details, and market news. Track MRNA performance on NASDAQ.
NASDAQ
15-minute delay
MODERNA, INC. COVERAGE
Latest Moderna, Inc. news
MARKET NEWS
Around the market
fool.com · Nov 9, 2026
Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy
Read article →
zacks.com · Nov 9, 2026
Can Moderna's First Cancer Therapy Win FDA Approval in 2027?
Read article →
zacks.com · Nov 9, 2026
Moderna Q3 Earnings Call Highlights Raised Outlook and Oncology
Read article →
fool.com · Nov 9, 2026
BioNTech vs. Moderna: The COVID Vaccine Giants Are Entering a New Era.
Read article →
fool.com · Nov 8, 2026
Moderna: 3 Key Takeaways for Long-Term Investors
Read article →KEY DATA POINTS
Financial snapshot
Revenue, profitability, balance-sheet, cash-flow, and valuation trends for Moderna, Inc..
NASDAQ MARKET COMPARABLES
Similar companies
Ten established NASDAQ listings presented for broader market context.
NASDAQ reference
15-minute delay
AAPL
Apple
Large-cap technology
→
MSFT
Microsoft
Enterprise technology
→
NVDA
NVIDIA
AI & semiconductors
→
AMZN
Amazon
Commerce & cloud
→
GOOGL
Alphabet
Internet & AI
→
META
Meta Platforms
Digital platforms
→
AVGO
Broadcom
Semiconductors
→
TSLA
Tesla
Electric vehicles
→
COST
Costco
Consumer retail
→
NFLX
Netflix
Streaming media
→
TradingView renders the market-data table. Securities.io supplies only the editorial peer selection, comparison labels, and destination links.
COMPANY DETAILS
About Moderna, Inc.
Business description, sector, industry, leadership, headquarters, and workforce information.
SECURITIES.IO RESEARCH
Continue your research
NASDAQ market data on this page is labeled as 15 minutes delayed. Prices, charts, financials, company information, and the peer comparison are displayed by TradingView; Securities.io does not extract those values. This information is educational and is not investment advice.